MUMBAI, India, March 13 -- Intellectual Property India has published a patent application (202641025521 A) filed by Vignan Institute Of Pharmaceutical Technology, Visakhapatnam, Andhra Pradesh, on March 4, for 'microfluidic chip-based nmr for metabolite profiling in personalized medicine drug monitoring.'
Inventor(s) include G. Anusha; K. Varaprasada Rao; K. Sridevi Ranjitha; K. B. R Babu; D. Vasudha; and P. Mounica.
The application for the patent was published on March 13, under issue no. 11/2026.
According to the abstract released by the Intellectual Property India: "The invention introduces a compact microfluidic chip integrated with nuclear magnetic resonance (NMR) technology specifically designed for profiling metabolites in patient samples to support personalized medicine, particularly in monitoring drug responses. This system enables rapid, non-invasive analysis of small biological fluid volumes, such as blood or urine, to detect and quantify key metabolites that indicate how a patient is metabolizing a prescribed drug. By combining microfluidics for precise sample handling with miniaturized NMR detection, it offers high sensitivity and specificity without the need for large equipment or extensive sample preparation. The approach enhances drug monitoring by providing real-time insights into therapeutic effectiveness, potential toxicity, and dosage adjustments, ultimately improving patient outcomes through tailored treatments. This novel integration addresses limitations in traditional metabolomics methods, such as high costs and time delays, making it suitable for point-of-care applications in clinical settings."
Disclaimer: Curated by HT Syndication.
